Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01293214 · ClinicalTrials.gov registry record · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
A NA study of Limb Amputation and Extremity Amputation, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01293214 is a NA study of Limb Amputation and Extremity Amputation that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01293214, a NA study of Limb Amputation and Extremity Amputation, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Limb transplantation surgery is the transfer of one or more limbs from a deceased human donor to a patient with single or multiple limb amputation. Hand transplantation is an innovative reconstructive procedure that has the potential to significantly improve the lives of hand amputees. The purpose of this study is to develop the best practices for multiple limb transplantation that will improve the outcomes of future limb transplant recipients.
Conditions Studied
Interventions
- PROCEDURE Limb transplantation
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-02-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01293214
The ClinicalTrials.gov registry entry for NCT01293214 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Limb Amputation appearing as the primary indexed condition, and to 1 intervention - of which Limb transplantation is the first listed.
NCT01293214 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01293214 about?
NCT01293214 is a clinical study titled "Vascularized Composite Allotransplantation for Multiple Extremity Amputations". Limb transplantation surgery is the transfer of one or more limbs from a deceased human donor to a patient with single or multiple limb amputation. Hand transplantation is an innovative reconstructive procedure that has the potential to significantly improve the lives of hand amputees. The purpose o...
What is the current status of trial NCT01293214?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2010-02-01. Estimated completion is 2026-12-31.
What conditions does trial NCT01293214 study?
This clinical trial studies the following conditions: Limb Amputation, Extremity Amputation.
What interventions are being tested in trial NCT01293214?
The interventions under investigation include: Limb transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT01293214?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01293214 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.